STOCK TITAN

Ynvisible to Deliver First E-paper Displays for Medical At-Home Tests

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary

Ynvisible announced a collaboration with a global medical device leader to develop advanced e-paper displays for at-home diagnostic tests, complying with FDA regulations. The company received an order for over 10,000 units to be delivered by year-end, with potential annual volumes reaching 10 million units post-FDA approval. These ultra-low-power, sustainable displays offer cost-effective, energy-efficient solutions, aiming to replace traditional display technologies. Ynvisible is investing in R&D, marketing, and production capabilities to enhance competitiveness and product portfolio for mass production. Details about the customer and product specifics remain confidential due to strategic agreements.

Positive
  • Received an order for over 10,000 e-paper display units, signaling strong demand.
  • Potential annual order volumes could reach 10 million units post-FDA approval.
  • The innovative e-paper displays are cost-effective and energy-efficient, enhancing market competitiveness.
  • Investments in R&D, marketing, and production capabilities to support high-volume indicator applications.
Negative
  • The success of future orders and market expansion is contingent on FDA approval.
  • Confidentiality agreements limit transparency about the customer and product specifics.

Vancouver, British Columbia--(Newsfile Corp. - June 26, 2024) - Ynvisible Interactive Inc. (TSXV: YNV) (FSE: 1XNA) (OTCQB: YNVYF) (the "Company" or "Ynvisible"), a leading provider of printed low-power e-paper display products, is pleased to announce a collaboration with a global industry leader in medical devices, to develop the next generation of medical at-home testing and diagnostic devices. The customized displays that Ynvisible developed for this application follow strict medical industry requirements, to comply with FDA regulations, and can become a standard solution in a wide range of medical and diagnostics products. Ynvisible has received a purchase order for more than 10,000 units for this new type of display, which will be delivered until the end of the year.

The ultra-low-power, sustainable printed e-paper displays developed by Ynvisible can replace more traditional display technologies, working as a thinner, easier to integrate and more energy-efficient visual interface, to convey important information to the user.

For the customer, switching to this innovative solution is expected to significantly increase market share over the coming years, due to the cost-effectiveness and energy efficiency of Ynvisible's e-paper displays, coupled with the advantages of roll-to-roll manufacturing.

The new Ynvisible display required a high degree of customization and technological fine tuning, due to strict regulations in medical testing devices. A batch of more than 10,000 displays will be shipped until the end of the year for verification, validation, clinical testing and FDA approval. The projected order volumes for this application reach 10 million units per year.

Once this device is approved by the FDA, Ynvisible anticipates additional announcements in a range of medical and diagnostic categories. This initiative validates Ynvisible's strategic focus on developing indicators designed for mass production and widespread application. To reinforce this initiative, Ynvisible is committing to targeted investments in key areas such as research and development, marketing outreach, and enhancement of production capabilities. These focused investments are set to enhance Ynvisible's product portfolio and market competitiveness, reinforcing the strategy for high-volume indicator applications.

Due to confidentiality agreements, Ynvisible cannot reveal the customer's name or disclose the specific design and functionalities of the product at this time. These agreements are crucial to protecting the customer's competitive advantage, reflecting the strategic value and significance of this collaboration.

About Ynvisible

Ynvisible is disrupting the low-cost and ultra-low-power display industry thanks to the latest advantages in sustainable electronics and roll-to-roll printing production. Ynvisible's printed e-paper displays are ideal for low-power and cost-sensitive applications, such as digital signage, smart monitoring labels, authenticity and security, and retail labels and signage. Ynvisible has the experience, know-how, and intellectual property in electrochromic materials, inks, and systems and offers a mix of services, materials, and technology to brand owners developing smart objects and IoT products. Additional information on Ynvisible is available at www.ynvisible.com.

Upcoming Ynvisible Webinar

Join Ynvisible's investor-focused webinar on Wednesday, June 26, 2024, at 4:00 pm (CET) / 10:00 am (EST). CEO Ramin Heydarpour and the executive team will highlight progress in product development, customer acquisition, and market strategy. Investors will gain insights into technical and commercial achievements, future prospects, and strategic initiatives. Register here.

ON BEHALF OF THE BOARD OF DIRECTORS

Ramin Heydarpour
CEO and Executive Chairman

Ynvisible Interactive Inc.
For further information, please contact:
Investor Relations
+1 778-683-4324
ir@ynvisible.com

Public Relations
pr@ynvisible.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains certain statements that may be deemed "forward-looking" statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although Ynvisible Interactive Inc. believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual results may differ materially from those in forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of Ynvisible Interactive Inc. management on the date the statements are made. Except as required by law, Ynvisible Interactive Inc. undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/214439

FAQ

What is the recent collaboration announced by Ynvisible related to?

Ynvisible announced a collaboration to develop advanced e-paper displays for at-home medical diagnostic tests.

What is the expected delivery volume for Ynvisible's e-paper displays in 2024?

Ynvisible expects to deliver over 10,000 e-paper display units by the end of 2024.

What are the potential future annual order volumes for Ynvisible's e-paper displays?

The potential future annual order volumes for Ynvisible's e-paper displays could reach 10 million units.

When will Ynvisible's e-paper displays be delivered for verification and validation?

Ynvisible's e-paper displays will be delivered for verification and validation by the end of 2024.

What are the advantages of Ynvisible's e-paper displays?

Ynvisible's e-paper displays are ultra-low-power, sustainable, cost-effective, and energy-efficient.

Why has Ynvisible signed confidentiality agreements regarding their recent collaboration?

Confidentiality agreements protect the customer's competitive advantage and strategic value.

What investments is Ynvisible making to support its strategic focus?

Ynvisible is investing in R&D, marketing outreach, and production capabilities to enhance its product portfolio and competitiveness.

Which regulatory approval is necessary for the success of Ynvisible's e-paper displays?

FDA approval is necessary for the success and mass production of Ynvisible's e-paper displays.

YNVISIBLE INTERACTIVE INC

OTC:YNVYF

YNVYF Rankings

YNVYF Latest News

YNVYF Stock Data

11.56M
127.04M
1.91%
Electronic Components
Technology
Link
United States of America
Vancouver